The other study reporting on the effects of naltrexone-bupropion in genetic obesity, is a case report about 1 patient with a heterozygous pathogenic MC4R variant and an extensive medical history, including bariatric surgery and liraglutide treatment, with insufficient effect. This evidence concerns the gene MC4R and Genetic obesity.